323
Views
37
CrossRef citations to date
0
Altmetric
Gastrointestinal Hormones

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population

, , , , &
Pages 564-570 | Received 18 Nov 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lars Agréus, Ernst J Kuipers, Limas Kupcinskas, Peter Malfertheiner, Francesco Di Mario, Marcis Leja, Varocha Mahachai, Niv Yaron, Martijn van Oijen, Guillermo Perez Perez, Massimo Rugge, Jukka Ronkainen, Mikko Salaspuro, Pentti Sipponen, Kentaro Sugano & Joseph Sung. (2012) Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scandinavian Journal of Gastroenterology 47:2, pages 136-147.
Read now
Peter L. M. Jansen. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:5, pages 516-517.
Read now

Articles from other publishers (35)

Shuxia Qin, Xuehong Wang, Sini Li, Meiyu Wu & Xiaomin Wan. (2024) Personalizing age of gastric cancer screening based on comorbidity in China: Model estimates of benefits, affordability and cost-effectiveness optimization. Preventive Medicine 179, pages 107851.
Crossref
Sun-Young Lee. (2023) Type A, Type B, and Non-atrophic Gastritis. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 23:2, pages 108-117.
Crossref
Sun-Young Lee. (2022) Comparison of Gastric Cancer Screening Strategies between Helicobacter pylori-infected, -eradicated, and -naive Individuals. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22:4, pages 313-316.
Crossref
Mimi C. Tan, Quynh Ho, Theresa H. Nguyen, Yan Liu, Hashem B. El-Serag & Aaron P. Thrift. (2021) Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Digestive Diseases and Sciences 67:9, pages 4500-4508.
Crossref
Cheol Min Shin. (2022) Acid Suppressive Drugs. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22:2, pages 119-130.
Crossref
Jong Hyeon Jeong, Sun-Young Lee & Hye Seung Han. (2022) Gastric Corpus Hypertrophy with a Bleeding Hyperplastic Polyp in a Helicobacter pylori-naive Subject after Long-term Proton Pump Inhibitor Use. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22:1, pages 63-69.
Crossref
Maidina Abuduwaili, Tomoyuki Boda, Masanori Ito, Hidehiko Takigawa, Takahiro Kotachi, Taiji Matsuo, Shiro Oka & Shinji Tanaka. (2022) Serum Gastrin and Pepsinogen Levels after Administration of Acid Secretion Inhibitors for Ulcers due to Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer. Gastroenterology Research and Practice 2022, pages 1-8.
Crossref
Myint N. Tun, Khin S. Aye & Than T. Aye. (2021) Diagnostic accuracy of serum pepsinogens for atrophic gastritis in Myanmar. GastroHep 3:6, pages 352-358.
Crossref
Gitark Noh, Nayoung Kim, Yonghoon Choi, Hye Seung Lee, Young Jae Hwang, Hee Jin Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park & Dong Ho Lee. (2020) Long‐term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication . Journal of Gastroenterology and Hepatology 35:9, pages 1540-1548.
Crossref
Rejane MATTAR, Sergio Barbosa MARQUES, Igor Braga RIBEIRO, Thiago Arantes de Carvalho VISCONTI, Mateus FUNARI & Eduardo Guimarães Hourneaux DE MOURA. (2020) DIAGNOSTIC ACCURACY OF GASTROPANEL® FOR ATROPHIC GASTRITIS IN BRAZILIAN SUBJECTS AND THE EFFECT OF PROTON PUMP INHIBITORS. Arquivos de Gastroenterologia 57:2, pages 154-160.
Crossref
Rui Wang & Xin-Zu Chen. (2020) Prevalence of atrophic gastritis in southwest China and predictive strength of serum gastrin-17: A cross-sectional study (SIGES). Scientific Reports 10:1.
Crossref
峰 李. (2019) Discussion from Gastrin on Bidirectional Regulating Effect of Acupuncture and Moxibustion on Chronic Atrophic Gastritis. Traditional Chinese Medicine 08:05, pages 301-307.
Crossref
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALHAES, Décio CHINZON, Marcelo CURY, Gerson DOMINGUES, Jorge Luiz JORGE, Ismael MAGUILNIK, Frederico Passos MARINHO, Joaquim Prado de MORAES-FILHO, José Miguel Luz PARENTE, Celso Mirra de PAULA-E-SILVA, José PEDRAZZOLI-JÚNIOR, Ana Flávia Passos RAMOS, Heinrich SEIDLER, José Nonato SPINELLI & José Vitor ZIR. (2018) IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arquivos de Gastroenterologia 55:2, pages 97-121.
Crossref
Vira Boichuk. (2018) THE ROLE OF PEPSINOGENES AND SOME INTESTINAL HORMONES IN PATHOGENESIS OF GASTROESOPHAGEAL REFLUX DISEASE. EUREKA: Health Sciences 1, pages 3-8.
Crossref
Jing Shan, Hongjun Lei, Wei Shi, Xiaobin Sun, Yu Tang & Chunrong Ren. (2018) High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury. Digestive Diseases 36:1, pages 66-71.
Crossref
Yuling Tong, Yulian Wu, Zhenya Song, Yingying Yu & Xinyan Yu. (2017) The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. BMC Gastroenterology 17:1.
Crossref
Elisabetta Goni, Marino Venerito, Christian Schulz, Jochen Weigt, Cosima Langner, Alexander Link & Peter Malfertheiner. (2017) Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17. European Journal of Gastroenterology & Hepatology 29:12, pages 1340-1345.
Crossref
R. M. Zagari, S. Rabitti, D. C. Greenwood, L. H. Eusebi, A. Vestito & F. Bazzoli. (2017) Systematic review with meta‐analysis: diagnostic performance of the combination of pepsinogen, gastrin‐17 and anti‐ Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis . Alimentary Pharmacology & Therapeutics 46:7, pages 657-667.
Crossref
Mariko Kiso, Masaharu Yoshihara, Masanori Ito, Kazuhiko Inoue, Katsuaki Kato, Shigemi Nakajima, Katsuhiro Mabe, Masao Kobayashi, Naomi Uemura, Tomoyuki Yada, Masashi Oka, Takashi Kawai, Tomoyuki Boda, Takahiro Kotachi, Kazuhiko Masuda, Shinji Tanaka & Kazuaki Chayama. (2016) Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. Gastric Cancer 20:5, pages 764-771.
Crossref
Mariam Martín-Alcolea, Inés Rodríguez-Hernández, Marta Aldea, Irene Rosas, Jordi Juncà & Maria Luisa Granada. (2017) Chronic proton pump inhibition therapy in the diagnostic accuracy of serum pepsinogen I and gastrin concentrations to identify pernicious anaemia. Clinical Biochemistry 50:9, pages 481-484.
Crossref
Jennifer M Yeh, Chin Hur, Zachary Ward, Deborah Schrag & Sue J Goldie. (2016) Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut 65:4, pages 563-574.
Crossref
K. Ashida, Y. Sakurai, A. Nishimura, K. Kudou, N. Hiramatsu, E. Umegaki, K. Iwakiri & T. Chiba. (2015) Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Alimentary Pharmacology & Therapeutics 42:6, pages 685-695.
Crossref
Ilva Daugule, Agnese Ruskule, Georgijs Moisejevs, Dace Rudzite, Laimas Jonaitis, Dainius Janciauskas, Gediminas Kiudelis, Limas Kupcinskas & Marcis Leja. (2015) Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 27:5, pages 501-505.
Crossref
Kari J. Syrjänen, Penti Sipponen, Matti Härkönen, Ants Peetsalu & Semi Korpela. (2015) Accuracy of the GastroPanel test in the detection of atrophic gastritis. European Journal of Gastroenterology & Hepatology 27:1, pages 102-104.
Crossref
Tomoyuki Yada, Koichi Ito, Keigo Suzuki, Koki Okubo, Yoichiro Aoki, Naoki Akazawa, Hitohiko Koizuka, Tsuyoshi Ishida & Naomi Uemura. (2014) Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor. Clinical Journal of Gastroenterology 7:6, pages 484-489.
Crossref
Franco Grimaldi, Nicola Fazio, Roberto Attanasio, Andrea Frasoldati, Enrico Papini, Francesco Angelini, Roberto Baldelli, Debora Berretti, Sara Bianchetti, Giancarlo Bizzarri, Marco Caputo, Roberto Castello, Nadia Cremonini, Anna Crescenzi, Maria Vittoria Davì, Angela Valentina D’Elia, Antongiulio Faggiano, Stefano Pizzolitto, Annibale Versari, Michele Zini, Guido Rindi & Kjell Öberg. (2014) Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Journal of Endocrinological Investigation 37:9, pages 875-909.
Crossref
Muneki Igarashi, Jun Nagano, Ayumi Tsuda, Takayoshi Suzuki, Jun Koike, Tetsufumi Uchida, Masashi Matsushima, Tetsuya Mine & Yasuhiro Koga. (2014) Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic. Pharmaceuticals 7:7, pages 754-764.
Crossref
Chikara Iino, Tadashi Shimoyama, Yoshihiro Sasaki, Manabu Sawaya, Norihiro Hanabata & Shinsaku Fukuda. (2012) Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer. Digestive Endoscopy 24:5, pages 339-342.
Crossref
Mitchell L. Schubert. 2012. Physiology of the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract 1281 1309 .
Aaron I. Vinik & Michael Raymund C. Gonzales. (2011) New and Emerging Syndromes due to Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 40:1, pages 19-63.
Crossref
Mark Ellrichmann, Peter R. Ritter, Henning Schrader, Wolfgang E. Schmidt, Juris J. Meier & Frank Schmitz. (2010) Gastrin stimulates the VEGF-A promotor in a human colon cancer cell line. Regulatory Peptides 165:2-3, pages 146-150.
Crossref
Matthew H. Kulke, Lowell B. Anthony, David L. Bushnell, Wouter W. de Herder, Stanley J. Goldsmith, David S. Klimstra, Stephen J. Marx, Janice L. Pasieka, Rodney F. Pommier, James C. Yao & Robert T. Jensen. (2010) NANETS Treatment Guidelines. Pancreas 39:6, pages 735-752.
Crossref
Aaron I. Vinik, Eugene A. Woltering, Richard R. P. Warner, Martyn Caplin, Thomas M. O'Dorisio, Gregory A. Wiseman, Domenico Coppola & Vay Liang W. Go. (2010) NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor. Pancreas 39:6, pages 713-734.
Crossref
Nauramy Osefo, Tetsuhide Ito & Robert T. Jensen. (2009) Gastric acid hypersecretory states: Recent insights and advances. Current Gastroenterology Reports 11:6, pages 433-441.
Crossref
Mitchell L Schubert. (2009) Gastric exocrine and endocrine secretion. Current Opinion in Gastroenterology 25:6, pages 529-536.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.